Insider Transactions in Q4 2021 at Minerva Surgical Inc (UTRS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
David M Clapper President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
93,500
+50.0%
|
-
|
|
Dec 15
2021
|
Dominique J. Filloux COO |
BUY
Grant, award, or other acquisition
|
Direct |
24,500
+10.62%
|
-
|
|
Dec 15
2021
|
Joel R Jung CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,500
+13.24%
|
-
|
|
Dec 15
2021
|
Evgueni V. Skalnyi VP Medical Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
20,250
+9.41%
|
-
|
|
Dec 13
2021
|
David M Clapper President and CEO |
BUY
Open market or private purchase
|
Indirect |
25,000
+3.74%
|
$100,000
$4.94 P/Share
|
|
Oct 26
2021
|
Ross A Md Jaffe Director |
BUY
Conversion of derivative security
|
Indirect |
94,755
+50.0%
|
-
|
|
Oct 26
2021
|
New Enterprise Associates 13 LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,300,000
+11.51%
|
$15,600,000
$12.0 P/Share
|
|
Oct 26
2021
|
New Enterprise Associates 13 LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
8,699,125
+39.58%
|
-
|
|
Oct 26
2021
|
Ali Behbahani Director |
BUY
Conversion of derivative security
|
Direct |
8,487
+41.12%
|
-
|
|
Oct 26
2021
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
580,000
+21.99%
|
$6,960,000
$12.0 P/Share
|
|
Oct 26
2021
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,477,132
+39.32%
|
-
|